Twist Bioscience (0ME) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0ME Analyst Ratings

Strong Buy

8 Buy

1 Hold

0 Sell

Based on 9 analysts giving stock ratings to

Twist

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0ME Stock 12 Month Forecast

Average Price Target

€76.88

▲(53.77% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is €76.88 with a high forecast of €93.62 and a low forecast of €56.87. The average price target represents a 53.77% change from the last price of €50.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","57":"€57","94":"€94","38.5":"€38.5","75.5":"€75.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":93.61747576,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€93.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76.88444563,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€76.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56.8704292,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€56.87</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,38.5,57,75.5,94],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.6,89.90903659692307,90.21807319384615,90.52710979076923,90.83614638769231,91.14518298461539,91.45421958153847,91.76325617846153,92.07229277538461,92.38132937230769,92.69036596923077,92.99940256615385,93.30843916307693,{"y":93.61747576,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.6,88.62188043307692,87.64376086615384,86.66564129923077,85.68752173230769,84.70940216538462,83.73128259846153,82.75316303153846,81.77504346461538,80.79692389769231,79.81880433076923,78.84068476384616,77.86256519692307,{"y":76.88444563,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.6,87.0823407076923,84.56468141538461,82.04702212307691,79.52936283076923,77.01170353846153,74.49404424615385,71.97638495384615,69.45872566153847,66.94106636923077,64.42340707692307,61.905747784615386,59.38808849230769,{"y":56.8704292,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":30.39,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.98,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.04,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.18,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€93.62

Average Price Target€76.88

Lowest Price Target€56.87

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Vijay Kumar

Evercore ISI

€57.75→€89.24

Hold

78.49%

Upside

Downgraded

07/06/26

Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI

Subbu Nambi

Guggenheim

€52.5→€93.62

Buy

87.23%

Upside

Reiterated

06/29/26

Twist Bioscience price target raised to $107 from $60 at GuggenheimTwist Bioscience price target raised to $107 from $60 at Guggenheim

Luke Sergott

Barclays

€56.87→€83.12

Buy

66.24%

Upside

Assigned

06/24/26

Twist Bioscience (TWST) Receives a Buy from Barclays

Brendan Smith

TD Cowen

€59.5→€77.87

Buy

55.74%

Upside

Assigned

06/15/26

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Twist Bioscience (TWST)

Kyle Mikson CFA

Canaccord Genuity

€78.74

Buy

57.49%

Upside

Initiated

06/15/26

Twist Bioscience initiated with a Buy at CanaccordTwist Bioscience initiated with a Buy at Canaccord

David Westenberg

Piper Sandler

€74.37

Buy

48.74%

Upside

Initiated

06/11/26

Twist Bioscience initiated with an Overweight at Piper SandlerTwist Bioscience initiated with an Overweight at Piper Sandler

Matt Larew

William Blair

―

Buy

―

Reiterated

05/26/26

Twist Bioscience Earns Buy Rating on AI-Driven Demand, Factory-of-the-Future Capacity and Path to EBITDA Breakeven

Catherine Ramsey Schulte

Robert W. Baird

€43.75→€56.87

Buy

13.74%

Upside

Reiterated

05/05/26

Twist Bioscience price target raised to $65 from $50 at BairdTwist Bioscience price target raised to $65 from $50 at Baird

Puneet Souda

Leerink Partners

€61.25

Buy

22.49%

Upside

Upgraded

05/05/26

Twist Bioscience upgraded to Outperform from Market Perform at LeerinkTwist Bioscience upgraded to Outperform from Market Perform at Leerink

Steven Etoch

Stephens

€35.87

Buy

-28.26%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Rachel Vatnsdal

J.P. Morgan

€28.87→€21.87

Sell

-56.25%

Downside

Reiterated

08/05/25

J.P. Morgan Keeps Their Sell Rating on Twist Bioscience (TWST)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Vijay Kumar

Evercore ISI

€57.75→€89.24

Hold

78.49%

Upside

Downgraded

07/06/26

Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI

Subbu Nambi

Guggenheim

€52.5→€93.62

Buy

87.23%

Upside

Reiterated

06/29/26

Twist Bioscience price target raised to $107 from $60 at GuggenheimTwist Bioscience price target raised to $107 from $60 at Guggenheim

Luke Sergott

Barclays

€56.87→€83.12

Buy

66.24%

Upside

Assigned

06/24/26

Twist Bioscience (TWST) Receives a Buy from Barclays

Brendan Smith

TD Cowen

€59.5→€77.87

Buy

55.74%

Upside

Assigned

06/15/26

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Twist Bioscience (TWST)

Kyle Mikson CFA

Canaccord Genuity

€78.74

Buy

57.49%

Upside

Initiated

06/15/26

Twist Bioscience initiated with a Buy at CanaccordTwist Bioscience initiated with a Buy at Canaccord

David Westenberg

Piper Sandler

€74.37

Buy

48.74%

Upside

Initiated

06/11/26

Twist Bioscience initiated with an Overweight at Piper SandlerTwist Bioscience initiated with an Overweight at Piper Sandler

Matt Larew

William Blair

―

Buy

―

Reiterated

05/26/26

Twist Bioscience Earns Buy Rating on AI-Driven Demand, Factory-of-the-Future Capacity and Path to EBITDA Breakeven

Catherine Ramsey Schulte

Robert W. Baird

€43.75→€56.87

Buy

13.74%

Upside

Reiterated

05/05/26

Twist Bioscience price target raised to $65 from $50 at BairdTwist Bioscience price target raised to $65 from $50 at Baird

Puneet Souda

Leerink Partners

€61.25

Buy

22.49%

Upside

Upgraded

05/05/26

Twist Bioscience upgraded to Outperform from Market Perform at LeerinkTwist Bioscience upgraded to Outperform from Market Perform at Leerink

Steven Etoch

Stephens

€35.87

Buy

-28.26%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Rachel Vatnsdal

J.P. Morgan

€28.87→€21.87

Sell

-56.25%

Downside

Reiterated

08/05/25

J.P. Morgan Keeps Their Sell Rating on Twist Bioscience (TWST)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BBOTBridgeBio Oncology Therapeutics

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Twist Bioscience

3 Months

Brendan SmithTD Cowen

Success Rate

9/14 ratings generated profit

Average Return

+17.63%

Copying Brendan Smith's trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +17.63% per trade.

1 Year

Brendan SmithTD Cowen

Success Rate

10/14 ratings generated profit

Average Return

+98.89%

Copying Brendan Smith's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +98.89% per trade.

2 Years

Brendan SmithTD Cowen

Success Rate

14/14 ratings generated profit

Average Return

+156.96%

Copying Brendan Smith's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +156.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0ME Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0ME has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0ME average Analyst price target in the past 3 months is 76.88.

Each month's total comprises the sum of three months' worth of ratings.

0ME Financial Forecast

0ME Earnings Forecast

Next quarter’s earnings estimate for 0ME is -€0.43 with a range of -€0.48 to -€0.34. The previous quarter’s EPS was -€0.62. 0ME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Sales Forecast

Next quarter’s sales forecast for 0ME is €100.31M with a range of €99.84M to €100.72M. The previous quarter’s sales results were €96.96M. 0ME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Stock Forecast FAQ

What is DE:0ME’s average 12-month price target, according to analysts?

Based on analyst ratings, Twist Bioscience’s 12-month average price target is 76.88.

What is DE:0ME’s upside potential, based on the analysts’ average price target?

Twist Bioscience has 53.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Twist Bioscience a Buy, Sell or Hold?

Twist Bioscience has a consensus rating of Strong Buy, which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.

What is Twist Bioscience’s share price target?

The average share price target for Twist Bioscience is 76.88. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €93.62 ,and the lowest forecast is €56.87. The average share price target represents 53.77% Increase from the current price of €50.

What do analysts say about Twist Bioscience?

Twist Bioscience’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Twist Bioscience?

To buy shares of DE:0ME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Twist Bioscience (0ME) Stock Forecast & Price Target

0ME Analyst Ratings

0ME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Twist Bioscience

0ME Analyst Recommendation Trends

0ME Financial Forecast

0ME Earnings Forecast

0ME Sales Forecast

0ME Stock Forecast FAQ

Detailed List of Analyst Forecasts